Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials

Xiu Hong Yanga Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China;b Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, ChinaView further author information

Bao Long Zhangc The Institutes of Biomedical Sciences (IBS), Fudan University, Shanghai, ChinaView further author information

Yun Chenga Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, ChinaView further author information

Shun Kun Fua Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, ChinaView further author information

Hui Min Jina Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China;d Department of Nephrology, The People’s Hospital of Wenshan Prefecture, Yunnan Province, ChinaCorrespondence[email protected]
View further author information

Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date